Masimo Corporation Stock

Equities

MASI

US5747951003

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-24 pm EDT 5-day change 1st Jan Change
127 USD +1.80% Intraday chart for Masimo Corporation +2.34% +8.35%
Sales 2024 * 2.1B Sales 2025 * 2.23B Capitalization 6.74B
Net income 2024 * 99M Net income 2025 * 163M EV / Sales 2024 * 2.26 x
Net cash position 2024 * 2B Net cash position 2025 * 1.74B EV / Sales 2025 * 2.25 x
P/E ratio 2024 *
69.5 x
P/E ratio 2025 *
42.7 x
Employees 3,800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 67.54%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.80%
1 week+2.34%
Current month-5.51%
1 month-6.56%
3 months-3.94%
6 months+35.01%
Current year+8.35%
More quotes
1 week
122.37
Extreme 122.365
127.62
1 month
112.85
Extreme 112.85
139.50
Current year
107.57
Extreme 107.57
153.93
1 year
75.22
Extreme 75.22
169.58
3 years
75.22
Extreme 75.22
305.21
5 years
75.22
Extreme 75.22
305.21
10 years
19.30
Extreme 19.3
305.21
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 89-04-30
Director of Finance/CFO 45 17-10-15
Chief Operating Officer 43 99-12-31
Members of the board TitleAgeSince
Director/Board Member 75 14-04-02
Chief Executive Officer 59 89-04-30
Director/Board Member 64 23-01-14
More insiders
Date Price Change Volume
24-05-24 127 +1.80% 606,517
24-05-23 124.8 -1.46% 777,765
24-05-22 126.6 +1.67% 328,968
24-05-21 124.5 -1.68% 583,225
24-05-20 126.6 +2.05% 820,504

Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT

More quotes
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
127 USD
Average target price
151.9 USD
Spread / Average Target
+19.60%
Consensus